Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (401-410 of 506) with videos related to

Pageof 51
Sort By:
European Heart Journal|June 29, 2017
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseAlida L P Caforio, Yehuda Adler, Carlo Agostini, et al.
Annals of the Rheumatic Diseases|February 2, 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR databaseQingran Yan, Cosimo Bruni, Alexandru Garaiman, et al.
Journal of Internal Medicine|November 28, 2023
Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohortKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Rheumatology (Oxford, England)|September 20, 2021
Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group RegistryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research DatabaseGemma Lepri, Cosimo Bruni, Lorenzo Tofani, et al.
Rheumatology (Oxford, England)|November 5, 2019
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group studyVeronika K Jaeger, Mohammed Tikly, Dong Xu, et al.
Journal of Autoimmunity|April 17, 2025
Treatment of mixed connective tissue disease: A multicenter retrospective studyKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Pageof 51

Showing results (401-410 of 506) with videos related to

Sort By:
Pageof 51
European Heart Journal|June 29, 2017
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseAlida L P Caforio, Yehuda Adler, Carlo Agostini, et al.
Annals of the Rheumatic Diseases|February 2, 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR databaseQingran Yan, Cosimo Bruni, Alexandru Garaiman, et al.
Journal of Internal Medicine|November 28, 2023
Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohortKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
Rheumatology (Oxford, England)|September 20, 2021
Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group RegistryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research DatabaseGemma Lepri, Cosimo Bruni, Lorenzo Tofani, et al.
Rheumatology (Oxford, England)|November 5, 2019
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group studyVeronika K Jaeger, Mohammed Tikly, Dong Xu, et al.
Journal of Autoimmunity|April 17, 2025
Treatment of mixed connective tissue disease: A multicenter retrospective studyKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Pageof 51